Pancreatic Cancer Research

ResearcherTohoku UniversityActive in the last 2 years

Yukinari Kato

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5385-8201; OpenAlex author ID A5060363731. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 5

  1. A Cancer-Specific Anti-Podocalyxin Monoclonal Antibody-Drug Conjugate Exerted Antitumor Activity in a Pancreatic Cancer Xenograft Model Last author DOI 10.20944/preprints202609.1232.v1↗
  2. A Cancer-Specific Monoclonal Antibody against Podocalyxin Exerted Antitumor Activities in Pancreatic Cancer Xenografts. Last author DOI 10.3390/ijms25010161↗
  3. H2Mab-19 Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody Therapy Exerts Antitumor Activity in Pancreatic Cancer Xenograft Models. Co-author DOI 10.1089/mab.2020.0011↗
  4. BACH1 Promotes Pancreatic Cancer Metastasis by Repressing Epithelial Genes and Enhancing Epithelial-Mesenchymal Transition. Co-author DOI 10.1158/0008-5472.can-18-4099↗
  5. Establishment of H2Mab-119, an Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody, Against Pancreatic Cancer. Last author DOI 10.1089/mab.2017.0050↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mika Kato Kaneko · 5 shared papers, 2017–2026 · strength 0.91
  2. Hiroyuki Suzuki · 2 shared papers, 2023–2026 · strength 0.62
  3. Takuro Nakamura · 2 shared papers, 2017–2026 · strength 0.46
  4. Shinji Yamada · 2 shared papers, 2017–2020 · strength 0.17
  5. Manabu Kawada · 1 shared paper, 2020 · strength 0.12
  6. Yuriko Saiki · 1 shared paper, 2020 · strength 0.09
  7. Keiko Nakayama · 1 shared paper, 2020 · strength 0.09
  8. Michiaki Unno · 1 shared paper, 2020 · strength 0.09
  9. Masaki Sato · 1 shared paper, 2020 · strength 0.09
  10. Kazuhiko Igarashi · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.